Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Ritvos

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 16, 2004
Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cellsNoora Kaivo-Oja, David G Mottershead, Sabine Mazerbourg, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 4, 2018
Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responsesTuuli A Nissinen, Jaakko Hentilä, Fabio Penna, et al.
Clinical Lung Cancer|November 18, 2019
Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based ChemotherapyJuuso Paajanen, Ilkka Ilonen, Helena Lauri, et al.
Gynecologic Oncology|November 23, 2016
Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumorsUlla-Maija Haltia, Marianne Hallamaa, Johanna Tapper, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 13, 2017
Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscleJuha J Hulmi, Tuuli A Nissinen, Markus Räsänen, et al.
Toxins|February 25, 2025
Soluble Activin Receptor Type IIB Improves Muscle Regeneration Following <i>Crotalus atrox</i> Venom-Induced DamageMedha Sonavane, Ali Alqallaf, Robert D Mitchell, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 5, 2024
Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction-associated steatotic liver disease in western diet/L-NAME induced cardiometabolic diseaseJulia Swan, Zoltán Szabó, Juliana Peters, et al.
Molecular and Cellular Biology|December 30, 2015
ActivinB Is Induced in Insulinoma To Promote Tumor Plasticity through a β-Cell-Induced DedifferentiationDoriane Ripoche, Jérémie Charbord, Ana Hennino, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 20, 2020
Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac functionZoltán Szabó, Laura Vainio, Ruizhu Lin, et al.
Reproduction (Cambridge, England)|April 6, 2006
Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term cultureInger B Carlsson, Mika P E Laitinen, Jennifer E Scott, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|October 16, 2004
Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cellsNoora Kaivo-Oja, David G Mottershead, Sabine Mazerbourg, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 4, 2018
Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responsesTuuli A Nissinen, Jaakko Hentilä, Fabio Penna, et al.
Clinical Lung Cancer|November 18, 2019
Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based ChemotherapyJuuso Paajanen, Ilkka Ilonen, Helena Lauri, et al.
Gynecologic Oncology|November 23, 2016
Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumorsUlla-Maija Haltia, Marianne Hallamaa, Johanna Tapper, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 13, 2017
Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscleJuha J Hulmi, Tuuli A Nissinen, Markus Räsänen, et al.
Toxins|February 25, 2025
Soluble Activin Receptor Type IIB Improves Muscle Regeneration Following <i>Crotalus atrox</i> Venom-Induced DamageMedha Sonavane, Ali Alqallaf, Robert D Mitchell, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 5, 2024
Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction-associated steatotic liver disease in western diet/L-NAME induced cardiometabolic diseaseJulia Swan, Zoltán Szabó, Juliana Peters, et al.
Molecular and Cellular Biology|December 30, 2015
ActivinB Is Induced in Insulinoma To Promote Tumor Plasticity through a β-Cell-Induced DedifferentiationDoriane Ripoche, Jérémie Charbord, Ana Hennino, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 20, 2020
Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac functionZoltán Szabó, Laura Vainio, Ruizhu Lin, et al.
Reproduction (Cambridge, England)|April 6, 2006
Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term cultureInger B Carlsson, Mika P E Laitinen, Jennifer E Scott, et al.
Pageof 9